person · Reporting owner

RANDLE STUART A

Disclosed activity across 4 companies

Tapewire entity: 40304
SEC CIK: 0001256144

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Comera Life Sciences Holdings, Inc.CMRA · Entity 94670	Director	August 31, 2023	September 01, 2023
Decoy Therapeutics Inc.FLKS · Entity 937	Director	July 25, 2018	July 26, 2018
TELEFLEX INCTFX · Entity 3798	Director	June 07, 2026	June 10, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Comera Life Sciences Holdings, Inc.

Report date August 31, 2023 · Filed September 01, 2023

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Stock Option (Right to Purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $0.70 · Expires 2033-08-10	Direct	96,378	Reported balance After 2023-08-31 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2023-08-31 · Grant · Acquired 96,378 · Balance 96,378 F1: The option grant was approved by the registrant's board of directors on August 10, 2023, subject to stockholder approval of an amendment to the Comera Life Sciences Holdings, Inc. 2022 Equity and Incentive Plan (the "Plan") under which the option was granted. The registrant's stockholders approved the Plan amendment on August 31, 2023. F3: In furtherance of the registrant's cash conservation efforts, the options were granted in lieu of the annual cash retainer and committee fees due to non-employee directors for the quarter ended June 30, 2023, in accordance with the registrant's February 2023 temporary modification to its non-employee director compensation plan. This option was issued to the reporting person in lieu of retainer fees of $20,625. For more information related to the registrant's non-employee director compensation plan and the February 2023 temporary modification, see the registrant's Annual Report on Form 10-K for the year ended December 31, 2022. F2: The options became fully vested on the date the Plan amendment was approved by the registrant's stockholders.

Filing footnotes · ownership attribution and instrument terms

F1: The option grant was approved by the registrant's board of directors on August 10, 2023, subject to stockholder approval of an amendment to the Comera Life Sciences Holdings, Inc. 2022 Equity and Incentive Plan (the "Plan") under which the option was granted. The registrant's stockholders approved the Plan amendment on August 31, 2023.

F2: The options became fully vested on the date the Plan amendment was approved by the registrant's stockholders.

F3: In furtherance of the registrant's cash conservation efforts, the options were granted in lieu of the annual cash retainer and committee fees due to non-employee directors for the quarter ended June 30, 2023, in accordance with the registrant's February 2023 temporary modification to its non-employee director compensation plan. This option was issued to the reporting person in lieu of retainer fees of $20,625. For more information related to the registrant's non-employee director compensation plan and the February 2023 temporary modification, see the registrant's Annual Report on Form 10-K for the year ended December 31, 2022.

Decoy Therapeutics Inc.

Report date July 25, 2018 · Filed July 26, 2018

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.82 · Expires 2028-07-25	Direct	10,000	Reported balance After 2018-07-25 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2018-07-25 · Grant · Acquired 10,000 · Balance 10,000 F1: The stock option will vest in 12 successive equal monthly installments measured from June 6, 2018.

Filing footnotes · ownership attribution and instrument terms

F1: The stock option will vest in 12 successive equal monthly installments measured from June 6, 2018.

TELEFLEX INC

Report date June 07, 2026 · Filed June 10, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	21,187	Ending reported balance After 2026-06-08 transaction · row 3 3 source rows · reconciled sequence Row 1 · 2026-06-07 · Tax withholding · Disposed 4,054 · Balance 15,529 F1: Shares withheld to satisfy tax liability upon vesting of restricted stock unit award. Row 2 · 2026-06-08 · Grant · Acquired 995 · Balance 16,524 F2: Restricted Stock Unit Award granted pursuant to the Teleflex Incorporated 2023 Stock Incentive Plan. Award vests 100% on 5/15/2027; provided, however, if the reporting person does not stand for re-election to the issuer's board of directors at the issuer's 2027 annual meeting of stockholders (the "2027 Annual Meeting"), the award will vest on the earlier of 5/15/2027 and the date of the 2027 Annual Meeting, so long as such meeting is held at least 50 weeks after the issuer's 2026 annual meeting of stockholders (the "2026 Annual Meeting"). Row 3 · 2026-06-08 · Grant · Acquired 4,663 · Balance 21,187 F3: Restricted Stock Unit Award granted pursuant to the Teleflex Incorporated 2023 Stock Incentive Plan. Award vests 100% on the earlier of the one-year anniversary of the grant date and the date of the 2027 Annual Meeting.
Stock Option / (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $131.74 · Expires 2036-06-08	Direct	2,192	Reported balance After 2026-06-08 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2026-06-08 · Grant · Acquired 2,192 · Balance 2,192 F4: Stock Option Award vests 100% on 5/15/2027; provided, however, if the reporting person does not stand for re-election to the Board at the 2027 Annual Meeting, the award will vest on the earlier of 5/15/2027 and the date of the 2027 Annual Meeting, so long as such meeting is held at least 50 weeks after the 2026 Annual Meeting.

Filing footnotes · ownership attribution and instrument terms

F1: Shares withheld to satisfy tax liability upon vesting of restricted stock unit award.

F2: Restricted Stock Unit Award granted pursuant to the Teleflex Incorporated 2023 Stock Incentive Plan. Award vests 100% on 5/15/2027; provided, however, if the reporting person does not stand for re-election to the issuer's board of directors at the issuer's 2027 annual meeting of stockholders (the "2027 Annual Meeting"), the award will vest on the earlier of 5/15/2027 and the date of the 2027 Annual Meeting, so long as such meeting is held at least 50 weeks after the issuer's 2026 annual meeting of stockholders (the "2026 Annual Meeting").

F3: Restricted Stock Unit Award granted pursuant to the Teleflex Incorporated 2023 Stock Incentive Plan. Award vests 100% on the earlier of the one-year anniversary of the grant date and the date of the 2027 Annual Meeting.

F4: Stock Option Award vests 100% on 5/15/2027; provided, however, if the reporting person does not stand for re-election to the Board at the 2027 Annual Meeting, the award will vest on the earlier of 5/15/2027 and the date of the 2027 Annual Meeting, so long as such meeting is held at least 50 weeks after the 2026 Annual Meeting.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

QXO BUILDING PRODUCTS, INC.

Report date April 29, 2025 · Filed April 29, 2025

Section 16 reporting ended · disclosed 2025-04-29. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Common Stock, $0.01 par valueSEC Table I · non-derivative	Direct	Reported balance After 2025-04-29 transaction · row 1 1 source row Row 1 · 2025-04-29 · Disposition to issuer · Disposed 25,970 · Balance 0 F1: Pursuant to an Agreement and Plan of Merger dated as of March 20, 2025 (the "Merger Agreement") by and among Beacon Roofing Supply, Inc. (the "Company"), QXO, Inc. ("QXO") and Queen MergerCo, Inc., a wholly owned subsidiary of QXO (the "Merger Sub"), the Merger Sub merged with and into the Company. Pursuant to the terms of the Merger Agreement, each share of Common Stock of the Company held by the Reporting Person was converted into the right to receive $124.35 in cash.
Restricted Stock Units (RSUs)SEC Table II · derivative / convertible security	Direct	Reported balance After 2025-04-29 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2025-04-29 · Disposition to issuer · Disposed 16,489 · Balance 0 F2: Each RSU represented a contingent right to receive one (1) share of Common Stock of the Company. F3: Pursuant to the terms of the Merger Agreement, each vested RSU held by the Reporting Person was converted into the right to receive $124.35 in cash. All such RSUs were fully vested prior to the date of the Merger Agreement, with retirement from the board the sole condition to settlement.
Restricted Stock Units (RSUs)SEC Table II · derivative / convertible security · Expires 2025-05-15	Direct	Reported balance After 2025-04-29 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2025-04-29 · Disposition to issuer · Disposed 1,400 · Balance 0 F2: Each RSU represented a contingent right to receive one (1) share of Common Stock of the Company. F4: Pursuant to the terms of the Merger Agreement, each unvested RSU held by the Reporting Person was converted into the right to receive $124.35 in cash. The RSUs were scheduled to vest on the date referenced in column 6.

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to an Agreement and Plan of Merger dated as of March 20, 2025 (the "Merger Agreement") by and among Beacon Roofing Supply, Inc. (the "Company"), QXO, Inc. ("QXO") and Queen MergerCo, Inc., a wholly owned subsidiary of QXO (the "Merger Sub"), the Merger Sub merged with and into the Company. Pursuant to the terms of the Merger Agreement, each share of Common Stock of the Company held by the Reporting Person was converted into the right to receive $124.35 in cash.

F2: Each RSU represented a contingent right to receive one (1) share of Common Stock of the Company.

F3: Pursuant to the terms of the Merger Agreement, each vested RSU held by the Reporting Person was converted into the right to receive $124.35 in cash. All such RSUs were fully vested prior to the date of the Merger Agreement, with retirement from the board the sole condition to settlement.

F4: Pursuant to the terms of the Merger Agreement, each unvested RSU held by the Reporting Person was converted into the right to receive $124.35 in cash. The RSUs were scheduled to vest on the date referenced in column 6.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
June 08, 2026 Filed Jun 10, 2026 00:32 UTC	TELEFLEX INC TFX · Entity 3798	GrantStock Option / (Right to Buy) · Derivative	2,192	$0.00 Strike: $131.74	$0.00	Disclosure SEC source: 0000096943-26-000078 · wk-form4_1781051548.xml · derivative · entry 4 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,192 Underlying: Common Stock · 2,192 shares Expires 2036-06-08 F4 · derivative.exercise_date: Stock Option Award vests 100% on 5/15/2027; provided, however, if the reporting person does not stand for re-election to the Board at the 2027 Annual Meeting, the award will vest on the earlier of 5/15/2027 and the date of the 2027 Annual Meeting, so long as such meeting is held at least 50 weeks after the 2026 Annual Meeting. Read SEC document
June 08, 2026 Filed Jun 10, 2026 00:32 UTC	TELEFLEX INC TFX · Entity 3798	GrantCommon Stock	4,663	$0.00	$0.00	Disclosure SEC source: 0000096943-26-000078 · wk-form4_1781051548.xml · nonDerivative · entry 3 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,187 F3 · kind: Restricted Stock Unit Award granted pursuant to the Teleflex Incorporated 2023 Stock Incentive Plan. Award vests 100% on the earlier of the one-year anniversary of the grant date and the date of the 2027 Annual Meeting. Read SEC document
June 08, 2026 Filed Jun 10, 2026 00:32 UTC	TELEFLEX INC TFX · Entity 3798	GrantCommon Stock	995	$0.00	$0.00	Disclosure SEC source: 0000096943-26-000078 · wk-form4_1781051548.xml · nonDerivative · entry 2 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,524 F2 · kind: Restricted Stock Unit Award granted pursuant to the Teleflex Incorporated 2023 Stock Incentive Plan. Award vests 100% on 5/15/2027; provided, however, if the reporting person does not stand for re-election to the issuer's board of directors at the issuer's 2027 annual meeting of stockholders (the "2027 Annual Meeting"), the award will vest on the earlier of 5/15/2027 and the date of the 2027 Annual Meeting, so long as such meeting is held at least 50 weeks after the issuer's 2026 annual meeting of stockholders (the "2026 Annual Meeting"). Read SEC document
June 07, 2026 Filed Jun 10, 2026 00:32 UTC	TELEFLEX INC TFX · Entity 3798	Tax withholdingCommon Stock	4,054	$129.84	$526,371.36	Disclosure SEC source: 0000096943-26-000078 · wk-form4_1781051548.xml · nonDerivative · entry 1 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,529 F1 · shares: Shares withheld to satisfy tax liability upon vesting of restricted stock unit award. Read SEC document
May 09, 2026 Filed May 13, 2026 00:24 UTC	TELEFLEX INC TFX · Entity 3798	Tax withholdingCommon Stock	289	$133.06	$38,454.34	Disclosure SEC source: 0000096943-26-000052 · wk-form4_1778631864.xml · nonDerivative · entry 1 RANDLE STUART A · CIK 0001256144 · Director · Interim President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,583 F1 · shares: Shares withheld to satisfy tax liability upon vesting of restricted stock unit award. Read SEC document
January 13, 2026 Filed Jan 16, 2026 00:18 UTC	TELEFLEX INC TFX · Entity 3798	GrantCommon Stock	12,325	$0.00	$0.00	Disclosure SEC source: 0001256144-26-000002 · wk-form4_1768522701.xml · nonDerivative · entry 1 RANDLE STUART A · CIK 0001256144 · Director · Interim President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,872 F1 · kind: Restricted Stock Unit Award granted pursuant to the Teleflex Incorporated 2023 Stock Incentive Plan in conjunction with Reporting Person's appointment as Interim President and CEO. Award vests on the earlier of the date on which a permanent Chief Executive Officer commences employment with the Company or January 13, 2027, subject to Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document
August 05, 2025 Filed Aug 7, 2025 22:02 UTC	TELEFLEX INC TFX · Entity 3798	PurchaseCommon Stock	1,000	$115.86	$115,860.00	Disclosure SEC source: 0000096943-25-000130 · wk-form4_1754604117.xml · nonDerivative · entry 1 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,547 F1 · price: This transaction was executed in multiple trades at prices ranging from $115.53 to $116.06. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document
May 09, 2025 Filed May 13, 2025 21:02 UTC	TELEFLEX INC TFX · Entity 3798	GrantStock Option / (Right to Buy) · Derivative	2,226	$0.00 Strike: $125.11	$0.00	Disclosure SEC source: 0000096943-25-000088 · wk-form4_1747170119.xml · derivative · entry 2 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,226 Underlying: Common Stock · 2,226 shares Expires 2035-05-09 F2 · derivative.exercise_date: If the reporting person does not stand for re-election to the issuer's board of directors at the issuer's 2026 annual meeting of stockholders (the "2026 Annual Meeting"), the award will vest on the earlier of the one-year anniversary of the grant date and the date of the 2026 Annual Meeting, so long as such meeting is held at least 50 weeks after the issuer's 2025 annual meeting of stockholders. Read SEC document
May 09, 2025 Filed May 13, 2025 21:02 UTC	TELEFLEX INC TFX · Entity 3798	GrantCommon Stock	1,051	$0.00	$0.00	Disclosure SEC source: 0000096943-25-000088 · wk-form4_1747170119.xml · nonDerivative · entry 1 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,547 F1 · kind: Restricted Stock Unit Award granted pursuant to the Teleflex Incorporated 2023 Stock Incentive Plan. Award vests on the one-year anniversary of the grant date; provided, however, if the reporting person does not stand for re-election to the issuer's board of directors at the issuer's 2026 annual meeting of stockholders (the "2026 Annual Meeting"), the award will vest on the earlier of the one-year anniversary of the grant date and the date of the 2026 Annual Meeting, so long as such meeting is held at least 50 weeks after the issuer's 2025 annual meeting of stockholders. Read SEC document
April 29, 2025 Filed Apr 29, 2025 13:29 UTC	QXO BUILDING PRODUCTS, INC. BECN · Entity 80418	Disposition to issuerRestricted Stock Units (RSUs) · Derivative	1,400	$124.35	$174,090.00	Disclosure SEC source: 0001562180-25-003330 · primarydocument.xml · derivative · entry 3 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.01 par value · 1,400 shares Expires 2025-05-15 F2 · derivative.exercise_price: Each RSU represented a contingent right to receive one (1) share of Common Stock of the Company. F4 · kind: Pursuant to the terms of the Merger Agreement, each unvested RSU held by the Reporting Person was converted into the right to receive $124.35 in cash. The RSUs were scheduled to vest on the date referenced in column 6. Read SEC document
April 29, 2025 Filed Apr 29, 2025 13:29 UTC	QXO BUILDING PRODUCTS, INC. BECN · Entity 80418	Disposition to issuerRestricted Stock Units (RSUs) · Derivative	16,489	$124.35	$2,050,407.15	Disclosure SEC source: 0001562180-25-003330 · primarydocument.xml · derivative · entry 2 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.01 par value · 16,489 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represented a contingent right to receive one (1) share of Common Stock of the Company. F3 · kind: Pursuant to the terms of the Merger Agreement, each vested RSU held by the Reporting Person was converted into the right to receive $124.35 in cash. All such RSUs were fully vested prior to the date of the Merger Agreement, with retirement from the board the sole condition to settlement. F3 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, each vested RSU held by the Reporting Person was converted into the right to receive $124.35 in cash. All such RSUs were fully vested prior to the date of the Merger Agreement, with retirement from the board the sole condition to settlement. F3 · derivative.expiration_date: Pursuant to the terms of the Merger Agreement, each vested RSU held by the Reporting Person was converted into the right to receive $124.35 in cash. All such RSUs were fully vested prior to the date of the Merger Agreement, with retirement from the board the sole condition to settlement. Read SEC document
April 29, 2025 Filed Apr 29, 2025 13:29 UTC	QXO BUILDING PRODUCTS, INC. BECN · Entity 80418	Disposition to issuerCommon Stock, $0.01 par value	25,970	$124.35	$3,229,369.50	Disclosure SEC source: 0001562180-25-003330 · primarydocument.xml · nonDerivative · entry 1 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: Pursuant to an Agreement and Plan of Merger dated as of March 20, 2025 (the "Merger Agreement") by and among Beacon Roofing Supply, Inc. (the "Company"), QXO, Inc. ("QXO") and Queen MergerCo, Inc., a wholly owned subsidiary of QXO (the "Merger Sub"), the Merger Sub merged with and into the Company. Pursuant to the terms of the Merger Agreement, each share of Common Stock of the Company held by the Reporting Person was converted into the right to receive $124.35 in cash. Read SEC document
August 16, 2024 Filed Aug 16, 2024 21:25 UTC	TELEFLEX INC TFX · Entity 3798	Exercise / conversionStock Option / (Right to Buy) · Derivative	2,674	$0.00 Strike: $121.00	$0.00	Disclosure SEC source: 0000096943-24-000136 · wk-form4_1723843524.xml · derivative · entry 3 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,674 shares Expires 2025-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
August 16, 2024 Filed Aug 16, 2024 21:25 UTC	TELEFLEX INC TFX · Entity 3798	SaleCommon Stock	2,674	$238.93	$638,898.82	Disclosure SEC source: 0000096943-24-000136 · wk-form4_1723843524.xml · nonDerivative · entry 2 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,496 Read SEC document
August 16, 2024 Filed Aug 16, 2024 21:25 UTC	TELEFLEX INC TFX · Entity 3798	Exercise / conversionCommon Stock	2,674	$121.00	$323,554.00	Disclosure SEC source: 0000096943-24-000136 · wk-form4_1723843524.xml · nonDerivative · entry 1 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,170 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
May 24, 2024 Filed May 28, 2024 16:17 UTC	QXO BUILDING PRODUCTS, INC. BECN · Entity 80418	GiftCommon Stock, $0.01 par value	500	$0.00	$0.00	Disclosure SEC source: 0001562180-24-004461 · primarydocument.xml · nonDerivative · entry 2 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,970 Read SEC document
May 23, 2024 Filed May 28, 2024 16:17 UTC	QXO BUILDING PRODUCTS, INC. BECN · Entity 80418	SaleCommon Stock, $0.01 par value	7,000	$94.80	$663,600.00	Disclosure SEC source: 0001562180-24-004461 · primarydocument.xml · nonDerivative · entry 1 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,470 F1 · price: This transaction was executed in multiple trades at prices ranging from $94.51 USD to $94.95 USD; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes, upon request, to provide to Beacon Roofing Supply, Inc. (the "Issuer"), any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document
May 17, 2024 Filed May 17, 2024 16:17 UTC	QXO BUILDING PRODUCTS, INC. BECN · Entity 80418	Exercise / conversionRestricted Stock Units (RSUs) · Derivative	2,053	$0.00	$0.00	Disclosure SEC source: 0001562180-24-004168 · primarydocument.xml · derivative · entry 3 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.01 par value · 2,053 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of BECN common stock. F3 · derivative.exercise_date: On May 17, 2023, the reporting individual was granted restricted stock units which vested and settled on the first anniversary of the grant date. F3 · derivative.expiration_date: On May 17, 2023, the reporting individual was granted restricted stock units which vested and settled on the first anniversary of the grant date. Read SEC document
May 17, 2024 Filed May 17, 2024 16:17 UTC	QXO BUILDING PRODUCTS, INC. BECN · Entity 80418	Exercise / conversionCommon Stock, $0.01 par value	2,053	$0.00	$0.00	Disclosure SEC source: 0001562180-24-004168 · primarydocument.xml · nonDerivative · entry 1 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,470 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
May 15, 2024 Filed May 17, 2024 16:17 UTC	QXO BUILDING PRODUCTS, INC. BECN · Entity 80418	GrantRestricted Stock Units (RSUs) · Derivative	1,400	$0.00	$0.00	Disclosure SEC source: 0001562180-24-004168 · primarydocument.xml · derivative · entry 2 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,400 Underlying: Common Stock, $0.01 par value · 1,400 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of BECN common stock. F2 · derivative.exercise_date: Restricted Stock Units vest on the first anniversary of the date of grant. F2 · derivative.expiration_date: Restricted Stock Units vest on the first anniversary of the date of grant. Read SEC document
May 07, 2024 Filed May 9, 2024 23:03 UTC	TELEFLEX INC TFX · Entity 3798	GrantStock Option / (Right to Buy) · Derivative	1,349	$0.00 Strike: $201.52	$0.00	Disclosure SEC source: 0000096943-24-000090 · wk-form4_1715295788.xml · derivative · entry 2 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,349 Underlying: Common Stock · 1,349 shares Expires 2034-05-07 F2 · derivative.exercise_date: If the reporting person does not stand for re-election to the issuer's board of directors at the issuer's 2025 annual meeting of stockholders (the "2025 Annual Meeting"), the award will vest on the earlier of the one-year anniversary of the grant date and the date of the 2025 Annual Meeting, so long as such meeting is held at least 50 weeks after the issuer's 2024 annual meeting of stockholders. Read SEC document
May 07, 2024 Filed May 9, 2024 23:03 UTC	TELEFLEX INC TFX · Entity 3798	GrantCommon Stock	649	$0.00	$0.00	Disclosure SEC source: 0000096943-24-000090 · wk-form4_1715295788.xml · nonDerivative · entry 1 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,496 F1 · kind: Restricted Stock Unit Award granted pursuant to the Teleflex Incorporated 2023 Stock Incentive Plan. Award vests on the one-year anniversary of the grant date; provided, however, if the reporting person does not stand for re-election to the issuer's board of directors at the issuer's 2025 annual meeting of stockholders (the "2025 Annual Meeting"), the award will vest on the earlier of the one-year anniversary of the grant date and the date of the 2025 Annual Meeting, so long as such meeting is held at least 50 weeks after the issuer's 2024 annual meeting of stockholders. Read SEC document
August 31, 2023 Filed Sep 1, 2023 20:43 UTC	Comera Life Sciences Holdings, Inc. CMRA · Entity 94670	GrantStock Option (Right to Purchase) · Derivative	96,378	$0.00 Strike: $0.70	$0.00	Disclosure SEC source: 0001062993-23-017438 · form4.xml · derivative · entry 1 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,378 Underlying: Common Stock · 96,378 shares Expires 2033-08-10 F1 · date: The option grant was approved by the registrant's board of directors on August 10, 2023, subject to stockholder approval of an amendment to the Comera Life Sciences Holdings, Inc. 2022 Equity and Incentive Plan (the "Plan") under which the option was granted. The registrant's stockholders approved the Plan amendment on August 31, 2023. F3 · price: In furtherance of the registrant's cash conservation efforts, the options were granted in lieu of the annual cash retainer and committee fees due to non-employee directors for the quarter ended June 30, 2023, in accordance with the registrant's February 2023 temporary modification to its non-employee director compensation plan. This option was issued to the reporting person in lieu of retainer fees of $20,625. For more information related to the registrant's non-employee director compensation plan and the February 2023 temporary modification, see the registrant's Annual Report on Form 10-K for the year ended December 31, 2022. F2 · derivative.exercise_date: The options became fully vested on the date the Plan amendment was approved by the registrant's stockholders. Read SEC document
June 08, 2023 Filed Jun 12, 2023 16:24 UTC	QXO BUILDING PRODUCTS, INC. BECN · Entity 80418	SaleCommon Stock, $0.01 par value	10,299	$72.43	$745,956.57	Disclosure SEC source: 0001562180-23-005083 · primarydocument.xml · nonDerivative · entry 1 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,417 F1 · price: This transaction was executed in multiple trades at prices ranging from $72.12 USD to $72.92 USD; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes, upon request, to provide to Beacon Roofing Supply, Inc. (the "Issuer"), any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document
May 17, 2023 Filed May 19, 2023 16:23 UTC	QXO BUILDING PRODUCTS, INC. BECN · Entity 80418	GrantRestricted Stock Units (RSUs) · Derivative	2,053	$0.00	$0.00	Disclosure SEC source: 0001562180-23-004301 · primarydocument.xml · derivative · entry 1 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,053 Underlying: Common Stock, $0.01 par value · 2,053 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of BECN common stock. F2 · derivative.exercise_date: Restricted Stock Units vest on the first anniversary of the date of grant. F2 · derivative.expiration_date: Restricted Stock Units vest on the first anniversary of the date of grant. Read SEC document
May 12, 2023 Filed May 16, 2023 21:50 UTC	Comera Life Sciences Holdings, Inc. CMRA · Entity 94670	GrantStock Option (Right to Purchase) · Derivative	56,662	$0.00 Strike: $0.69	$0.00	Disclosure SEC source: 0001062993-23-011256 · form4.xml · derivative · entry 1 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,662 Underlying: Common Stock · 56,662 shares Expires 2033-05-12 F2 · price: In furtherance of the registrant's cash conservation efforts, the options were granted in lieu of the annual cash retainer and committee fees due to non-employee directors for the quarter ended March 31, 2023, in accordance with the registrant's February 2023 temporary modification to its non-employee director compensation plan. This option was issued to the reporting person in lieu of retainer fees of $20,625. For more information related to the registrant's non-employee director compensation plan and the February 2023 temporary modification, see the registrant's Annual Report on Form 10-K for the year ended December 31, 2022. F1 · derivative.exercise_date: Granted pursuant to the Comera Life Sciences Holdings, Inc. 2022 Equity and Incentive Plan. The options were fully vested on the date of grant. Read SEC document
May 10, 2023 Filed May 11, 2023 21:52 UTC	TELEFLEX INC TFX · Entity 3798	Exercise / conversionStock Option / (Right to Buy) · Derivative	3,021	$0.00 Strike: $101.12	$0.00	Disclosure SEC source: 0000096943-23-000068 · wf-form4_168384194846005.xml · derivative · entry 5 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,021 shares Expires 2024-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
May 10, 2023 Filed May 11, 2023 21:52 UTC	TELEFLEX INC TFX · Entity 3798	SaleCommon Stock	3,021	$245.71	$742,289.91	Disclosure SEC source: 0000096943-23-000068 · wf-form4_168384194846005.xml · nonDerivative · entry 3 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,847 F2 · price: This transaction was executed in multiple trades at prices ranging from $245.66 to $245.92. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document
May 10, 2023 Filed May 11, 2023 21:52 UTC	TELEFLEX INC TFX · Entity 3798	Exercise / conversionCommon Stock	3,021	$101.12	$305,483.52	Disclosure SEC source: 0000096943-23-000068 · wf-form4_168384194846005.xml · nonDerivative · entry 2 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,868 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
May 09, 2023 Filed May 11, 2023 21:52 UTC	TELEFLEX INC TFX · Entity 3798	GrantStock Option / (Right to Buy) · Derivative	1,076	$0.00 Strike: $251.99	$0.00	Disclosure SEC source: 0000096943-23-000068 · wf-form4_168384194846005.xml · derivative · entry 4 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,076 Underlying: Common Stock · 1,076 shares Expires 2033-05-09 Read SEC document
May 09, 2023 Filed May 11, 2023 21:52 UTC	TELEFLEX INC TFX · Entity 3798	GrantCommon Stock	527	$0.00	$0.00	Disclosure SEC source: 0000096943-23-000068 · wf-form4_168384194846005.xml · nonDerivative · entry 1 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,847 F1 · kind: Restricted Stock Unit Award granted pursuant to the Teleflex Incorporated 2023 Stock Incentive Plan. Award vests on May 9, 2024. Read SEC document
March 10, 2023 Filed Mar 14, 2023 16:28 UTC	QXO BUILDING PRODUCTS, INC. BECN · Entity 80418	Exercise / conversionRestricted Stock Units (RSUs) · Derivative	2,204	$0.00	$0.00	Disclosure SEC source: 0001562180-23-002761 · primarydocument.xml · derivative · entry 2 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.01 par value · 2,204 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of BECN common stock. F2 · derivative.exercise_date: On March 10, 2022, the reporting individual was granted restricted stock units which vested and settled on the first anniversary of the grant date. F2 · derivative.expiration_date: On March 10, 2022, the reporting individual was granted restricted stock units which vested and settled on the first anniversary of the grant date. Read SEC document
March 10, 2023 Filed Mar 14, 2023 16:28 UTC	QXO BUILDING PRODUCTS, INC. BECN · Entity 80418	Exercise / conversionCommon Stock, $0.01 par value	2,204	$0.00	$0.00	Disclosure SEC source: 0001562180-23-002761 · primarydocument.xml · nonDerivative · entry 1 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,716 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
February 14, 2023 Filed Feb 16, 2023 23:32 UTC	Comera Life Sciences Holdings, Inc. CMRA · Entity 94670	GrantStock Option (Right to Purchase) · Derivative	7,100	$0.00 Strike: $1.30	$0.00	Disclosure SEC source: 0001062993-23-003847 · form4.xml · derivative · entry 1 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,100 Underlying: Common Stock · 7,100 shares Expires 2033-02-14 F1 · derivative.exercise_date: The stock option vests in 12 equal monthly installments beginning on March 14, 2023 such that the option will be fully vested on February 14, 2024, subject to continuous service to the issuer through each vesting date. Read SEC document
January 04, 2023 Filed Jan 6, 2023 21:14 UTC	Comera Life Sciences Holdings, Inc. CMRA · Entity 94670	GrantWarrants (right to buy) · Derivative	33,783	$0.25 Strike: $1.23	$8,445.75	Disclosure SEC source: 0001062993-23-000609 · form4.xml · derivative · entry 3 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,783 Underlying: Common Stock · 67,566 shares Expires 2028-01-04 F1 · derivative.exercise_price: The reporting person entered into a Securities Purchase Agreement with the Issuer on January 2, 2023, pursuant to which, on January 4, 2023, the reporting person acquired an aggregate of 33,783 units (the "Units") for a purchase price of $1.48 per Unit. Each Unit consists of one share of common stock, par value $0.0001 per share (the "Common Stock"), and one warrant (the "Warrants") to purchase two shares of Common Stock (the "Warrant Shares") at an exercise price of $1.23 per share. Each Warrant is immediately exercisable and expires five years from the date of issuance. The purchase price for each Unit includes $0.125 for each Warrant Share, or $0.25 per Warrant, in accordance with Nasdaq rules. F3 · shares: The exercisability of the Warrants is subject to a 4.99% beneficial ownership limitation. Read SEC document
January 04, 2023 Filed Jan 6, 2023 21:14 UTC	Comera Life Sciences Holdings, Inc. CMRA · Entity 94670	GrantCommon Stock	33,783	$1.23	$41,553.09	Disclosure SEC source: 0001062993-23-000609 · form4.xml · nonDerivative · entry 1 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,469 F1 · price: The reporting person entered into a Securities Purchase Agreement with the Issuer on January 2, 2023, pursuant to which, on January 4, 2023, the reporting person acquired an aggregate of 33,783 units (the "Units") for a purchase price of $1.48 per Unit. Each Unit consists of one share of common stock, par value $0.0001 per share (the "Common Stock"), and one warrant (the "Warrants") to purchase two shares of Common Stock (the "Warrant Shares") at an exercise price of $1.23 per share. Each Warrant is immediately exercisable and expires five years from the date of issuance. The purchase price for each Unit includes $0.125 for each Warrant Share, or $0.25 per Warrant, in accordance with Nasdaq rules. Read SEC document
January 04, 2023 Filed Feb 14, 2023 22:42 UTC Amendment	Comera Life Sciences Holdings, Inc. CMRA · Entity 94670	PurchaseWarrant (Right to Buy) · Derivative	33,783	$0.25 Strike: $1.23	$8,445.75	Disclosure SEC source: 0001062993-23-003510 · form4a.xml · derivative · entry 2 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,783 Underlying: Common Stock · 67,566 shares Expires 2028-01-04 F2 · derivative.exercise_price: The reporting person entered into a Securities Purchase Agreement with the Issuer on January 2, 2023, pursuant to which, on January 4, 2023, the reporting person acquired an aggregate of 33,783 units (the "Units") for a purchase price of $1.48 per Unit. Each Unit consists of one share of common stock, par value $0.0001 per share (the "Common Stock"), and one warrant (the "Warrants") to purchase two shares of Common Stock (the "Warrant Shares") at an exercise price of $1.23 per share. Each Warrant is immediately exercisable and expires five years from the date of issuance. The purchase price for each Unit includes $0.125 for each Warrant Share, or $0.25 per Warrant, in accordance with Nasdaq rules. F1 · kind: This Form 4/A is being filed to (i) correct a typographical error in the transaction code disclosed in Column 3 in Table I and Column 4 in Table II in the original Form 4, filed on January 6, 2023, from "A" to "P" and (ii) correct a typographical error in the power-of-attorney of the reporting person. F3 · shares: The exercisability of the Warrants is subject to a 4.99% beneficial ownership limitation. Read SEC document
January 04, 2023 Filed Feb 14, 2023 22:42 UTC Amendment	Comera Life Sciences Holdings, Inc. CMRA · Entity 94670	PurchaseCommon Stock	33,783	$1.23	$41,553.09	Disclosure SEC source: 0001062993-23-003510 · form4a.xml · nonDerivative · entry 1 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,469 F1 · kind: This Form 4/A is being filed to (i) correct a typographical error in the transaction code disclosed in Column 3 in Table I and Column 4 in Table II in the original Form 4, filed on January 6, 2023, from "A" to "P" and (ii) correct a typographical error in the power-of-attorney of the reporting person. F2 · price: The reporting person entered into a Securities Purchase Agreement with the Issuer on January 2, 2023, pursuant to which, on January 4, 2023, the reporting person acquired an aggregate of 33,783 units (the "Units") for a purchase price of $1.48 per Unit. Each Unit consists of one share of common stock, par value $0.0001 per share (the "Common Stock"), and one warrant (the "Warrants") to purchase two shares of Common Stock (the "Warrant Shares") at an exercise price of $1.23 per share. Each Warrant is immediately exercisable and expires five years from the date of issuance. The purchase price for each Unit includes $0.125 for each Warrant Share, or $0.25 per Warrant, in accordance with Nasdaq rules. Read SEC document
June 07, 2022 Filed Jun 9, 2022 21:33 UTC	TELEFLEX INC TFX · Entity 3798	Exercise / conversionStock Option / (Right to Buy) · Derivative	3,014	$0.00 Strike: $78.50	$0.00	Disclosure SEC source: 0000096943-22-000079 · wf-form4_165481040886360.xml · derivative · entry 3 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,014 shares Expires 2023-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
June 07, 2022 Filed Jun 9, 2022 21:33 UTC	TELEFLEX INC TFX · Entity 3798	SaleCommon Stock	3,014	$283.31	$853,896.34	Disclosure SEC source: 0000096943-22-000079 · wf-form4_165481040886360.xml · nonDerivative · entry 2 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,320 F1 · price: This transaction was executed in multiple trades at prices ranging from $283.12 to $283.56. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document
June 07, 2022 Filed Jun 9, 2022 21:33 UTC	TELEFLEX INC TFX · Entity 3798	Exercise / conversionCommon Stock	3,014	$78.50	$236,599.00	Disclosure SEC source: 0000096943-22-000079 · wf-form4_165481040886360.xml · nonDerivative · entry 1 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,334 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
May 19, 2022 Filed Feb 14, 2023 22:50 UTC	Comera Life Sciences Holdings, Inc. CMRA · Entity 94670	GrantStock Option (Right to Buy) · Derivative	44,981	Not disclosed Strike: $0.59	Not disclosed	Disclosure SEC source: 0001062993-23-003513 · form5.xml · derivative · entry 1 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,981 Underlying: Common Stock · 44,981 shares Expires 2031-09-16 F2 · price: This option was issued pursuant to the terms of a business combination agreement involving the issuer and Comera Life Sciences, Inc. in exchange for a comparable option previously issued by such company. F1 · derivative.exercise_date: The shares underlying the option vest in 48 equal monthly installments beginning on September 16, 2021. Read SEC document
May 03, 2022 Filed May 5, 2022 13:52 UTC	TELEFLEX INC TFX · Entity 3798	GrantStock Option / (Right to Buy) · Derivative	969	$0.00 Strike: $284.85	$0.00	Disclosure SEC source: 0000096943-22-000061 · wf-form4_165175874239884.xml · derivative · entry 2 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 969 Underlying: Common Stock · 969 shares Expires 2032-05-03 Read SEC document
May 03, 2022 Filed May 5, 2022 13:52 UTC	TELEFLEX INC TFX · Entity 3798	GrantCommon Stock	399	$0.00	$0.00	Disclosure SEC source: 0000096943-22-000061 · wf-form4_165175874239884.xml · nonDerivative · entry 1 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,320 F1 · kind: Restricted Stock Unit Award granted pursuant to Teleflex Incorporated 2014 Stock Incentive Plan. Award vests on November 3, 2022. Read SEC document
March 10, 2022 Filed Mar 14, 2022 18:48 UTC	QXO BUILDING PRODUCTS, INC. BECN · Entity 80418	GrantRestricted Stock Units (RSUs) · Derivative	2,204	$0.00	$0.00	Disclosure SEC source: 0001562180-22-002601 · primarydocument.xml · derivative · entry 1 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,204 Underlying: Common Stock, $0.01 par value · 2,204 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of BECN common stock. F2 · derivative.exercise_date: Restricted Stock Units vest on the first anniversary of the date of grant. F2 · derivative.expiration_date: Restricted Stock Units vest on the first anniversary of the date of grant. Read SEC document
February 19, 2022 Filed Feb 22, 2022 16:23 UTC	QXO BUILDING PRODUCTS, INC. BECN · Entity 80418	Exercise / conversionRestricted Stock Units (RSUs) · Derivative	2,753	$0.00	$0.00	Disclosure SEC source: 0001562180-22-001683 · primarydocument.xml · derivative · entry 2 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.01 par value · 2,753 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of BECN common stock. F2 · derivative.exercise_date: On February 19, 2021, the reporting individual was granted restricted stock units which vested and settled on the first anniversary of the grant date. F2 · derivative.expiration_date: On February 19, 2021, the reporting individual was granted restricted stock units which vested and settled on the first anniversary of the grant date. Read SEC document
February 19, 2022 Filed Feb 22, 2022 16:23 UTC	QXO BUILDING PRODUCTS, INC. BECN · Entity 80418	Exercise / conversionCommon Stock, $0.01 par value	2,753	$0.00	$0.00	Disclosure SEC source: 0001562180-22-001683 · primarydocument.xml · nonDerivative · entry 1 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,512 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
June 04, 2021 Filed Jun 8, 2021 21:03 UTC	TELEFLEX INC TFX · Entity 3798	Exercise / conversionStock Option / (Right to Buy) · Derivative	3,564	$0.00 Strike: $59.75	$0.00	Disclosure SEC source: 0000096943-21-000076 · wf-form4_162318617156693.xml · derivative · entry 5 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,564 shares Expires 2022-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
June 04, 2021 Filed Jun 8, 2021 21:03 UTC	TELEFLEX INC TFX · Entity 3798	GiftCommon Stock	278	$395.80	$110,032.40	Disclosure SEC source: 0000096943-21-000076 · wf-form4_162318617156693.xml · nonDerivative · entry 4 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,921 Read SEC document
June 04, 2021 Filed Jun 8, 2021 21:03 UTC	TELEFLEX INC TFX · Entity 3798	SaleCommon Stock	2,384	$395.66	$943,253.44	Disclosure SEC source: 0000096943-21-000076 · wf-form4_162318617156693.xml · nonDerivative · entry 3 RANDLE STUART A · CIK 0001256144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,199 F2 · price: This transaction was executed in multiple trades at prices ranging from $395.505 to $395.965. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.